Universal Ibogaine Inc.
OTC: IBOGF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Nicholas Peter Karos
- Employees
- 7
- Headquarters
- Calgary, Canada
- IPO year
- 2022
- Market cap
- $8.5M
- Website
- https://universalibogaine.com
Loading IBOGF…
Loading profile data…Frequently asked questions about IBOGF
What does Universal Ibogaine Inc. (IBOGF) do?
Universal Ibogaine Inc., a life sciences enterprise, focuses on developing, acquiring, and operating addiction treatment centers across Canada. The company is additionally preparing to launch clinical trials aimed at researching ibogaine's potential therapeutic applications for addiction. Its principal corporate offices are based in Calgary, Can...
Where does IBOGF trade?
Universal Ibogaine Inc. (IBOGF) trades on the Other OTC.
What sector is IBOGF in?
Universal Ibogaine Inc. (IBOGF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Universal Ibogaine Inc.?
Nicholas Peter Karos is the chief executive officer of Universal Ibogaine Inc. (IBOGF).
Where is Universal Ibogaine Inc. headquartered?
Universal Ibogaine Inc. is headquartered in Canada.
Does IBOGF pay a dividend?
Universal Ibogaine Inc. (IBOGF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IBOGF go public?
Universal Ibogaine Inc. (IBOGF) completed its initial public offering in 2022.